e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does tumor necrosis factor-α (TNFα) protect immune cells from apoptosis in lower airways?
P. Kopinski, J. Soja, A. Szlubowski, M. Plato, B. Balicka, G. Pinis, J. Szczeklik, K. Sladek (Bydgoszcz, Krakow, Poland)
Source:
Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session:
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session type:
Thematic Poster Session
Number:
777
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kopinski, J. Soja, A. Szlubowski, M. Plato, B. Balicka, G. Pinis, J. Szczeklik, K. Sladek (Bydgoszcz, Krakow, Poland). Does tumor necrosis factor-α (TNFα) protect immune cells from apoptosis in lower airways?. Eur Respir J 2007; 30: Suppl. 51, 777
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005
LSC Abstract – High mobility group box 1 modulates lung innate immunity by promoting wound healing and cytokine release in human bronchial epithelial cells
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Upregulation of the production of TGF-β and IL-4 and downregulation of IL-6 by apoptotic human bronchial epithelial cells: possible role in regulation of epithelial repair following acute lung injury
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001
Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction
Source: Eur Respir J 2012; 40: 424-435
Year: 2012
Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006
Proinflammatory effects of interferon beta (IFNβ) in virally infected bronchial epithelial cell cultures
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Club cells inhibit alveolar epithelial wound repair via TRAIL-dependent apoptosis
Source: Eur Respir J 2013; 41: 683-694
Year: 2013
TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021
Anti-inflammatory effect of adenovirus-mediated IκBα overexpression in respiratory epithelial cells
Source: Eur Respir J 2001; 18: 801-809
Year: 2001
Alternaria
fungal extracts disrupt the barrier function and induce secretion of inflammatory cytokines in airway epithelial cells
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Resistance of quiescent and proliferating airway epithelial cells to H2O2 challenge
Source: Eur Respir J 2007; 29: 633-642
Year: 2007
Interactions between neutrophils and NSCLC cells in vitro – effects on neutrophil inflammatory mediator generation and tumor cell proliferation
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Role of interferon-γ in tumor necrosis factor-α-mediated increase of lung microvascular endothelial cells
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Transforming growth factor beta (TGF-β) augments rhinovirus (RV) replication in primary bronchial epithelial cells (pbecs) through modulation of the innate immune response
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001
Physiomer(R) reduces the chemokine interleukin-;8 production by activated human respiratory epithelial cells
Source: Eur Respir J 2001; 18: 661-666
Year: 2001
Primary bronchial epithelial cells from stable lung allografts induce the differentiation of monocytes into macrophage like cells
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease
in vitro
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept